Posted Thursday, May 26, 2016 4:48 PM
Bryan / College Station
The Bryan/College Station area is experiencing continued heavy rainfall with several flooded roads. For your safety, please continue monitoring local weather and do not attempt to cross flooded roadways. Remember, turn around, don’t drown.
Michigan State University,
Postdoctoral training in the Department of Pharmacology & Toxicology, 1981 and 1983
University of Nebraska Medical Center,
St. Louis College of Pharmacy,
B.S. in pharmacy, 1975
Dr. Kennedy joined the faculty at the University of Arkansas for Medical Sciences (UAMS) and rose through the academic ranks from Instructor to Full Professor in the Department of Pharmacology & Toxicology between 1983 and 1997. From 1995 to 1997 he also served half time as the Vice-President for EPSCoR Research at the Arkansas Science and Technology Authority, a state agency focusing on the development of a competitive statewide research infrastructure. In 1998, he assumed chairmanship of the newly combined Department of Pharmaceutical Sciences in the School of Pharmacy at UAMS, and in 2002 he also became Dean of the Graduate School at that institution. He moved to Loyola in 2004.
He has been the major advisor for eight doctoral students, including one combined MD/PhD recipient, and has trained three postdoctoral students, numerous medical students doing research projects, and three clinical fellows. His research in cardiovascular pharmacology and pathophysiology has resulted in more than 105 peer-reviewed manuscripts and has been funded by a variety of agencies including the National Institutes of Health (both independent investigator grants and a Research Career Development Award), the American Heart Association (AHA), the National Collegiate Athletic Association (NCAA), the Office of Naval Research, the US Air Force, the Department of Defense and the Environmental Protection Agency (EPA). In addition, he was principal investigator on an NIGMS-funded R25 Minority Bridging Award, which was designed to attract M.S. graduates from the University of Arkansas at Pine Bluff, a primarily minority campus in the Delta region of Arkansas, to doctoral programs at UAMS, and an EPA-EPSCoR program designed to enhance toxicology research in Arkansas via enhanced electronic communications and pilot funding. Dr. Kennedy has served regularly on various peer-review groups including NIH, the AHA, the Veterans Affairs (VA) Merit Program, the American Diabetes Association and the British Columbia Health Care Research Foundation.